作者: JOSE MUNITA SEPULVEDA , Nagendra N Mishra , Danya Alvarez , Truc T Tran , Lorena Diaz
DOI: 10.1093/CID/CIU642
关键词:
摘要: High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 µg/mL) harboring genetic changes associated DAP resistance, persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against E. strains minimum concentrations >2 µg/mL.